Phase I Study of Chiauranib in Patients With Advanced Solid Tumors
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this dose-escalation study is to assess the safety and tolerability of
treatment with Chiauranib administered orally over a range of doses in patients with advanced
solid tumors.